Cognis Announces Price Increase for Betatene® Natural Mixed Carotenoids

La Grange, Ill., Dec. 21, 2007 – Cognis Nutrition & Health announced price increases for Betatene® natural mixed carotenoids—the first price hike in more than three years. New prices are effective for Betatene® orders placed to ship after Jan. 28, 2008. Factors contributing to the pricing changes include escalating costs for manufacturing, energy, raw materials, packaging, transportation, fuel, and currency exchanges.

“As the world’s leading supplier of algae-based natural beta-carotene, Cognis maintains two sites in Australia to secure supply using innovative, proprietary technology to produce the finest quality carotenoids with excellent stability,” said Rob Bailey, Marketing Manager, Cognis Nutrition & Health. “This price increase reflects the higher costs necessary to deliver the consistently high-quality Betatene® products our customers expect.”

For more information about Betatene® natural mixed carotenoids or to place an order, visit, call 800.673.3702, e-mail [email protected], or fax 513.482.3576.

About Cognis:

Cognis ( is a worldwide supplier of innovative specialty chemicals and nutritional ingredients, with a particular focus on the areas of wellness and sustainability. The company employs about 7,700 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The subsidiary Pulcra Chemicals offers specialized chemical products and process expertise to customers in the fiber, textile, and leather industries. Cognis also holds a 50-percent stake in the joint venture Cognis Oleochemicals, one of the world’s leading manufacturers of oleochemicals. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2006, Cognis recorded sales of 3.37 billion euros and an Adjusted EBITDA (operating result) of 394 million euros.


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.